10-12 September 2018 //  Lancaster Royal Hotel, London


Lincoln Tsang

Dr Lincoln Tsang

Partner, Life Science Practice, Arnold & Porter Kaye Scholer LLP

Lincoln  is a partner based in Arnold & Porter’s London office. His practice is focused on providing strategic cross-border regulatory, compliance, enforcement and litigation advice to the life sciences industry. He regularly undertakes internal investigations for companies. He also advises trade associations, foreign governments and charity/not-for-profit organizations. By ministerial appointment, Lincoln is currently a Commissioner of the British Pharmacopoeia Commission chairing its biologicals/biotechnology sub-committee and nomenclature committee; and has served as a non-executive member of the Regulatory Oversight Committee of the now defunct UK Health Protection Agency; a non-executive director of the board of the National Institute for Biological Standards and Control; a member of the Ministerial Industry Steering Group for pharmaceuticals. Lincoln was with the UK regulatory authority for nearly 13 years and latterly as the head of biological/biotechnology responsible a wide range of domestic and international legislative and policy matters. During his tenure, he served as advisor to the European Medicines Agency, the European Commission, and the World Health Organisation on international trade issues, and represented the European Commission at the International Conference on Harmonisation on matters relating to biological products. Most recently, he served as special advisor to the Council of Europe in developing the MediCrime Convention against counterfeited medical products. He was a member of the Council of the University College London School of Pharmacy and its governance and audit committees. He chaired the UK Bioindustry Association’s Regulatory Affairs Committee for two terms.


2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad